These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

209 related articles for article (PubMed ID: 25120790)

  • 1. Expression and clinical significance of cancer-testis genes in clear cell renal cell carcinoma.
    Yin B; Zeng Y; Wang X; Liu G; Zhang M; Song Y
    Int J Clin Exp Pathol; 2014; 7(7):4112-9. PubMed ID: 25120790
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Expression profile of cancer-testis genes in transitional cell carcinoma of the bladder.
    Yin B; Liu G; Wang XS; Zhang H; Song YS; Wu B
    Urol Oncol; 2012; 30(6):886-92. PubMed ID: 21396841
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression profile of cancer-testis genes in 121 human colorectal cancer tissue and adjacent normal tissue.
    Li M; Yuan YH; Han Y; Liu YX; Yan L; Wang Y; Gu J
    Clin Cancer Res; 2005 Mar; 11(5):1809-14. PubMed ID: 15756003
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pattern and clinical significance of cancer-testis gene expression in head and neck squamous cell carcinoma.
    Cuffel C; Rivals JP; Zaugg Y; Salvi S; Seelentag W; Speiser DE; Liénard D; Monnier P; Romero P; Bron L; Rimoldi D
    Int J Cancer; 2011 Jun; 128(11):2625-34. PubMed ID: 20715104
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical significance of immunohistochemical expression of cancer/testis tumor-associated antigens (MAGE-A1, MAGE-A3/4, NY-ESO-1) in patients with non-small cell lung cancer.
    Grah JJ; Katalinic D; Juretic A; Santek F; Samarzija M
    Tumori; 2014; 100(1):60-8. PubMed ID: 24675493
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Immunohistochemical expression of tumor antigens MAGE-A3/4 and NY-ESO-1 in renal oncocytoma and chromophobe renal cell carcinoma.
    Demirović A; Džombeta T; Tomas D; Spajić B; Pavić I; Hudolin T; Milošević M; Cupić H; Krušlin B
    Pathol Res Pract; 2010 Oct; 206(10):695-9. PubMed ID: 20591578
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Tumor-specific antigens in cutaneous T-cell lymphoma: expression and sero-reactivity.
    Eichmüller S; Usener D; Thiel D; Schadendorf D
    Int J Cancer; 2003 Apr; 104(4):482-7. PubMed ID: 12584747
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Rates of MAGE-A3 and PRAME expressing tumors in FFPE tissue specimens from bladder cancer patients: potential targets for antigen-specific cancer immunotherapeutics.
    Lerut E; Van Poppel H; Joniau S; Gruselle O; Coche T; Therasse P
    Int J Clin Exp Pathol; 2015; 8(8):9522-32. PubMed ID: 26464715
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Immunohystochemical expression of cancer/testis antigens (MAGE-A3/4, NY-ESO-1) in non-small cell lung cancer: the relationship with clinical-pathological features.
    Grah J; Samija M; Juretić A; Sarcević B; Sobat H
    Coll Antropol; 2008 Sep; 32(3):731-6. PubMed ID: 18982744
    [TBL] [Abstract][Full Text] [Related]  

  • 10. High expression of P53-induced Ring-h2 protein is associated with poor prognosis in clear cell renal cell carcinoma.
    Wu XR; Sha JJ; Liu DM; Chen YH; Yang GL; Zhang J; Chen YY; Bo JJ; Huang YR
    Eur J Surg Oncol; 2013 Jan; 39(1):100-6. PubMed ID: 23102595
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expression of cancer/testis (CT) antigens MAGE-A1, MAGE-A3, MAGE-A4, CT-7, and NY-ESO-1 in malignant gammopathies is heterogeneous and correlates with site, stage and risk status of disease.
    Dhodapkar MV; Osman K; Teruya-Feldstein J; Filippa D; Hedvat CV; Iversen K; Kolb D; Geller MD; Hassoun H; Kewalramani T; Comenzo RL; Coplan K; Chen YT; Jungbluth AA
    Cancer Immun; 2003 Jul; 3():9. PubMed ID: 12875607
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of the MAGE-A4 and NY-ESO-1 cancer-testis antigens and T cell infiltration in non-small cell lung carcinoma and their prognostic significance.
    Yoshida N; Abe H; Ohkuri T; Wakita D; Sato M; Noguchi D; Miyamoto M; Morikawa T; Kondo S; Ikeda H; Nishimura T
    Int J Oncol; 2006 May; 28(5):1089-98. PubMed ID: 16596224
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Expression of cancer-testis antigens in endometrial carcinomas using a tissue microarray.
    Chitale DA; Jungbluth AA; Marshall DS; Leitao MM; Hedvat CV; Kolb D; Spagnoli GC; Iversen K; Soslow RA
    Mod Pathol; 2005 Jan; 18(1):119-26. PubMed ID: 15272278
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Correlation between the high expression levels of cancer-germline genes with clinical characteristics in esophageal squamous cell carcinoma.
    Chen X; Wang L; Yue D; Liu J; Huang L; Yang L; Cao L; Qin G; Li A; Wang D; Wang M; Qi Y; Zhang B; van der Bruggen P; Zhang Y
    Histol Histopathol; 2017 Aug; 32(8):793-803. PubMed ID: 27868181
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Reduced expression of growth and differentiation factor-9 (GDF9) is associated with aggressive behaviour of human clear-cell renal cell carcinoma and poor patient survival.
    Du P; Ye L; Yang Y; Jiang WG
    Anticancer Res; 2014 Nov; 34(11):6515-20. PubMed ID: 25368253
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Activation of melanoma antigen tumor antigens occurs early in lung carcinogenesis.
    Jang SJ; Soria JC; Wang L; Hassan KA; Morice RC; Walsh GL; Hong WK; Mao L
    Cancer Res; 2001 Nov; 61(21):7959-63. PubMed ID: 11691819
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Combined cancer testis antigens enhanced prediction accuracy for prognosis of patients with hepatocellular carcinoma.
    Wang M; Li J; Wang L; Chen X; Zhang Z; Yue D; Ping Y; Shi X; Huang L; Zhang T; Yang L; Zhao Y; Ma X; Li D; Fan Z; Zhao L; Tang Z; Zhai W; Zhang B; Zhang Y
    Int J Clin Exp Pathol; 2015; 8(4):3513-28. PubMed ID: 26097535
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cancer/testis antigen expression and specific cytotoxic T lymphocyte responses in non small cell lung cancer.
    Groeper C; Gambazzi F; Zajac P; Bubendorf L; Adamina M; Rosenthal R; Zerkowski HR; Heberer M; Spagnoli GC
    Int J Cancer; 2007 Jan; 120(2):337-43. PubMed ID: 17066423
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MAGE-A3 is highly expressed in a subset of colorectal cancer patients.
    Shantha Kumara HM; Grieco MJ; Caballero OL; Su T; Ahmed A; Ritter E; Gnjatic S; Cekic V; Old LJ; Simpson AJ; Cordon-Cardo C; Whelan RL
    Cancer Immun; 2012; 12():16. PubMed ID: 23390371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Expression of MAGE-C1/CT7 and selected cancer/testis antigens in ovarian borderline tumours and primary and recurrent ovarian carcinomas.
    Zimmermann AK; Imig J; Klar A; Renner C; Korol D; Fink D; Stadlmann S; Singer G; Knuth A; Moch H; Caduff R
    Virchows Arch; 2013 May; 462(5):565-74. PubMed ID: 23529156
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.